DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Global Rett Syndrome Market: Industry Analysis & Outlook (2017-2025)" report to their offering.
The major players are Newron Pharmaceuticals, Neurem Pharmaceuticals Limited, Anavex Life Sciences Corp., Neuroloxis, and Edison Pharmaceuticals.
The global Rett syndrome market will grow over the years driven by increase in female population, rising spending on public healthcare programs, and increasing global healthcare expenditure. The major trends and developments of the market include efforts to use gene therapy to rectify this neurological disorder, development of new drugs and use of more efficient technologies. However, growth of the market is challenged by factors like high cost of treatment and high R&D expenditure.
The global Rett syndrome market has no direct indication approved drug and till date is treated by off label drugs. There is no cure to this disease. But many therapeutics are in their clinical phases and are being developed to treat severe symptoms of it like breathing disorder or seizure. With launch of potential drug candidates, the market will experience robust growth with higher penetration rate to treat this disease. The US will promulgate the introduction of these drugs and will be the largest market for Rett syndrome.
The major trends of the market include development of new drugs, use of gene therapy and expansion of new technologies. However, the market will be hindered by high R&D costs and high cost of treatment.
- Increasing Female Population Worldwide
- Rising Spending on Public Health Programs for Females
- Increased Spending on Medicines
- Increasing Global Healthcare Expenditure
Trends and Developments
- Gene Therapy for Rett Syndrome
- Development of New Drugs
- Development of More Efficient and Advanced Technology
Issues and Challenges
- High Cost of Treatment
- High R&D Costs
- Drug Progress Challenges in Developing Countries
Key Topics Covered:
1. Market Overview
2. Global Market Analysis
3. Regional Analysis
4. Market Dynamics
5. Competitive Landscape
6. Company Profiles
- Anavex Life Sciences Corp.
- Neuren Pharmaceuticals Limited
- Newron Pharmaceuticals
For more information about this report visit https://www.researchandmarkets.com/research/b3wzbd/global_rett